Welch & Forbes’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,802
Closed -$113K 383
2022
Q2
$113K Sell
10,802
-164
-1% -$1.8K ﹤0.01% 373
2022
Q1
$120K Sell
10,966
-7,443
-40% -$98.1K ﹤0.01% 383
2021
Q4
$249K Sell
18,409
-2,073
-10% -$27.7K ﹤0.01% 357
2021
Q3
$277K Sell
20,482
-4,658
-19% -$66.1K ﹤0.01% 350
2021
Q2
$359K Sell
25,140
-4,558
-15% -$65.9K 0.01% 329
2021
Q1
$415K Sell
29,698
-28,241
-49% -$460K 0.01% 302
2020
Q4
$1.09M Buy
+57,939
New +$945K 0.02% 210

Other funds holding VTRS

Welch & Forbes's VTRS Position: Q3 2022 in Review

Welch & Forbes sold out of Viatris (VTRS) in Q3 2022, closing a stake of 10,802 shares — an estimated $113K sold.

Welch & Forbes first reported a position in VTRS in Q4 2020 and held it in 7 quarters. The position peaked at $1.09M in Q4 2020. 980 funds tracked by Wall St. Rank hold VTRS as of Q3 2022.

  • Welch & Forbes reported no remaining Viatris position as of Q3 2022 after selling out during the quarter.
  • Welch & Forbes sold 10,802 Viatris shares in Q3 2022, an estimated $113K.
  • Welch & Forbes first reported a position in Viatris in Q4 2020 and held it in 7 quarters.
  • Welch & Forbes's Viatris position peaked at $1.09M in Q4 2020.
  • 980 funds tracked by Wall St. Rank held Viatris as of Q3 2022.

Based on Welch & Forbes's 13F filing for Q3 2022, filed 31 Oct 2022.